SION
Price:
$40.88
Market Cap:
$1.82B
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
Industry
Biotechnology
IPO Date
2025-02-07
Stock Exchange
NASDAQ
Ticker
SION
According to Sionna Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -62.72%. This represents a change of 66.69% compared to the average of -0.09% of the last 4 quarters.
The mean historical ROE of Sionna Therapeutics, Inc. over the last ten years is 45.46%. The current -62.72% ROE has changed -237.99% with respect to the historical average. Over the past ten years (40 quarters), SION's ROE was at its highest in in the December 2023 quarter at 10.34%. The ROE was at its lowest in in the June 2025 quarter at -5.37%.
Average
45.46%
Median
41.14%
Minimum
37.68%
Maximum
57.55%
Discovering the peaks and valleys of Sionna Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 57.55%
Minimum Annual Increase = -28.51%
Minimum Annual ROE = 37.68%
| Year | ROE | Change |
|---|---|---|
| 2024 | 37.68% | -8.41% |
| 2023 | 41.14% | -28.51% |
The current ROE of Sionna Therapeutics, Inc. (SION) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
45.46%
5-year avg
45.46%
10-year avg
45.46%
Sionna Therapeutics, Inc.’s ROE is greater than Janux Therapeutics, Inc. (-10.18%), greater than AbCellera Biologics Inc. (-16.95%), greater than Maze Therapeutics, Inc. (-44.62%), greater than Biohaven Ltd. (-389.88%), greater than Celldex Therapeutics, Inc. (-27.62%), greater than Vera Therapeutics, Inc. (-46.70%), less than Xeris Biopharma Holdings, Inc. (113.91%), greater than Zymeworks Inc. (-24.48%), greater than Ardelyx, Inc. (-36.91%), greater than Immunome, Inc. (-87.36%),
| Company | ROE | Market cap |
|---|---|---|
| -10.18% | $986.41M | |
| -16.95% | $1.09B | |
| -44.62% | $2.05B | |
| -389.88% | $1.02B | |
| -27.62% | $1.97B | |
| -46.70% | $2.72B | |
| 113.91% | $1.12B | |
| -24.48% | $1.99B | |
| -36.91% | $1.42B | |
| -87.36% | $1.84B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sionna Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sionna Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Sionna Therapeutics, Inc.'s ROE?
How is the ROE calculated for Sionna Therapeutics, Inc. (SION)?
What is the highest ROE for Sionna Therapeutics, Inc. (SION)?
What is the 3-year average ROE for Sionna Therapeutics, Inc. (SION)?
What is the 5-year average ROE for Sionna Therapeutics, Inc. (SION)?
How does the current ROE for Sionna Therapeutics, Inc. (SION) compare to its historical average?